Steering Board

Equally representing the sites of Munich, Münster and the Rhine-Main Neuroscience Network (rmn2), the role of the Steering Board is to – amongst other things – coordinate the needs of the individual research groups; examine membership applications; and present project and funding requests to the DFG on behalf of the CRC.

 

Prof. Dr. Heinz Wiendl Univ.-Prof. Prof. h.c. Dr. med. Heinz Wiendl (Münster), Spokesperson
Klinik für Neurologie
Universitätsklinikum der
Westfälischen Wilhelms-Universität Münster
E-Mail: heinz.wiendl@ukmuenster.de

 

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. med. Frauke Zipp (rmn2), Co-Spokesperson
Klinik und Poliklinik für Neurologie
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: frauke.zipp@unimedizin-mainz.de

 

 

 

Prof. Dr. Martin Kerschensteiner, Secretary
Institut für klinische Neuroimmunologie
Ludwig-Maximilians-Universität München
E-Mail: martin.kerschensteiner@med.uni-muenchen.de

 

 

 

 

Prof. Dr. Thomas Korn Prof. Dr. Thomas Korn
Neurologische Klinik und Poliklinik
Klinikum Rechts der Isar
Technische Universität München
E-Mail: thomas.korn@tum.de

 

 

 

Prof. Lydia Sorokin, PhDUniv.-Prof. Dr. rer. nat. Lydia Sorokin
Institut für Physiologische Chemie und Pathobiochemie
Westfälische Wilhelms-Universität Münster
E-Mail: sorokin@uni-muenster.de

 

 

 

 

Prof. Ari Waisman, PhD Univ.-Prof. Dr. rer. nat. Ari Waisman, PhD
Institut für Molekulare Medizin,
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
E-Mail: waisman@uni-mainz.de

News

Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more
Wed, 20/01/2021
A new study on neurological manifestations of severe COVID-19 reveals nervous system immune deficiency
Patients suffering from COVID-19 can develop concomitant and long-term symptoms in their nervous system. The most common symptom in this context is the loss of the sense of smell and taste, while more severe symptoms such as stroke, cerebral seizures, or meningitis are possible. A team of scientists from the medical faculties at the Universities […]...more